Kinnate Biopharma Inc.
KNTE
Revenue
0.00
0.000.00%
-Assets
173.61M
▼-17.10M▼-8.97%
3 Months ChangeLiabilities
14.28M
▼-4.01M▼-21.93%
3 Months ChangeFree Cash Flow
-27.73M
▼-4.63M▼-20.02%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-04-03
Form 8-K
ID: 0001193125-24-085548
2024-03-01
Form 8-K
ID: 0001140361-24-010648
2024-02-16
Form 8-K
ID: 0001140361-24-008282
2024-01-16
Form 8-K
ID: 0001140361-24-002334
2023-11-22
Form 8-K
ID: 0001140361-23-054438
2023-11-15
Form 8-K
ID: 0001140361-23-053357
2023-11-09
Form 10-Q
ID: 0001140361-23-052465
2023-11-09
Form 8-K
ID: 0001140361-23-052459
2023-09-18
Form 8-K
ID: 0001140361-23-044353
2023-08-08
Form 10-Q
ID: 0001140361-23-038597